FPT Long Chau Pharma Joint Stock Company wins at Healthcare Asia Pharma Awards 2026

The company’s community healthcare programme expands nationwide access and rapid disaster response.

FPT Long Chau Pharma Joint Stock Company has won Health and Wellness Initiative of the Year – Vietnam at the Healthcare Asia Pharma Awards 2026 for its Long Chau Care & Share initiative, recognising the company’s efforts to expand community healthcare access and deliver timely support during emergencies.

Community healthcare stands at the centre of FPT Long Chau Pharma Joint Stock Company’s sustainable development strategy. In 2022, the company established its presence across all 34 provinces and cities in Vietnam, becoming the first pharmacy chain in the country to achieve full nationwide coverage. This extensive network forms the foundation of its large-scale health outreach efforts, particularly in remote and underserved areas where access to medical services remains limited.

Launched in April 2021, the Long Chau Care & Share initiative provides medical support and health consultations to disadvantaged communities across Vietnam. The programme operates as a continuous series of charitable healthcare activities focused on practical and sustainable solutions. It offers free medication days, donates rice to support daily needs, and organises medical check-ups, consultations, and medicine distribution in rural and remote areas.

Over the past five years, thousands of Long Chau Care & Share journeys have travelled to villages and remote communities, delivering timely healthcare support to disadvantaged families.

In 2025 alone, Long Chau collaborated with local authorities, hospitals, and healthcare facilities nationwide to organise more than 170 free medical programmes, helping raise health awareness for nearly 30,000 people across the country.

At the same time, its network of over 2,400 pharmacies and more than 200 vaccination centres across all 34 provinces and cities continues to serve as a vital bridge between healthcare services and the community, encouraging proactive and science-based healthcare practices.

Continuing its mission to care for and protect public health, on 17 January, Long Chau Se Chia 2026 was officially launched, marking the sixth year of this sustained community initiative. This year’s programme begins with a nationwide stroke prevention campaign titled “Health Journey – Proactive Stroke Prevention for a Healthier Vietnam.” Through community screening activities, medical consultations, and public awareness programmes, the initiative encourages people to detect health risks early and take proactive steps to prevent stroke.

In response to natural disasters, Long Chau also rapidly mobilised 17 tonnes of essential medicines in 2024 and 2025 to support communities severely affected by storms and floods across Vietnam, ensuring timely access to healthcare during emergencies.

In addition, the system contributed 500,000 doses of measles vaccines to help expand immunisation coverage and strengthen protection for children against preventable diseases. These initiatives reaffirm Long Chau’s commitment to improving equitable access to essential healthcare for communities nationwide.

The Healthcare Asia Pharma Awards recognises outstanding companies that are redefining pharmaceutical excellence in Asia. The awards honour organisations whose innovative initiatives have significantly strengthened their businesses whilst delivering meaningful contributions to the healthcare sector.

The Healthcare Asia Pharma Awards is presented by Healthcare Asia Magazine. To view the full list of winners, click here. If you want to join the 2027 awards programme and be recognised for your organisation's innovative and unique initiatives that enhanced your business and remarkable contributions to the pharmaceutical industry, please contact Julie Anne Nuñez-Difuntorum at [email protected].